Static Chart Telix Pharmaceuticals Limited
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.00 AUD | +1.35% |
|
+7.53% | +33.93% |
| 07:19pm | Telix Enters Attractive Market With Late-Stage Brain Cancer Drug Trial in US, Jefferies Says | MT |
| Apr. 15 | Telix Pharmaceuticals Doses First Patient in Phase 3 Brain Cancer Trial | MT |
Select your edition
All financial news and data tailored to specific country editions
















